Medidata Solutions Inc (NASDAQ:MDSO) – Research analysts at Dougherty & Co issued their Q1 2018 earnings per share estimates for shares of Medidata Solutions in a research note issued on Monday. Dougherty & Co analyst G. Mannheimer forecasts that the company will earn $0.17 per share for the quarter. Dougherty & Co currently has a “Buy” rating and a $75.00 target price on the stock.
Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.31 by $0.10. The firm had revenue of $141.20 million for the quarter, compared to analyst estimates of $140.65 million. Medidata Solutions had a return on equity of 11.59% and a net margin of 8.14%. The company’s revenue was up 13.4% on a year-over-year basis. During the same period in the prior year, the company earned $0.33 EPS.
Medidata Solutions (MDSO) opened at $63.57 on Tuesday. The company has a current ratio of 1.50, a quick ratio of 3.37 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $3,661.76, a PE ratio of 71.82, a PEG ratio of 3.11 and a beta of 1.58. Medidata Solutions has a 1 year low of $54.36 and a 1 year high of $85.92.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. 1st Global Advisors Inc. lifted its holdings in Medidata Solutions by 0.5% in the 2nd quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock worth $645,000 after buying an additional 37 shares during the period. Bank of Nova Scotia lifted its holdings in Medidata Solutions by 7.7% in the 2nd quarter. Bank of Nova Scotia now owns 8,365 shares of the company’s stock worth $654,000 after buying an additional 600 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in Medidata Solutions by 11.0% in the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,534 shares of the company’s stock worth $666,000 after buying an additional 847 shares during the period. Meadow Creek Investment Management LLC lifted its holdings in Medidata Solutions by 31.4% in the 4th quarter. Meadow Creek Investment Management LLC now owns 3,680 shares of the company’s stock worth $233,000 after buying an additional 880 shares during the period. Finally, Essex Investment Management Co. LLC lifted its holdings in Medidata Solutions by 8.7% in the 4th quarter. Essex Investment Management Co. LLC now owns 11,085 shares of the company’s stock worth $702,000 after buying an additional 886 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.
In other Medidata Solutions news, CFO Rouven Bergmann sold 3,000 shares of the stock in a transaction that occurred on Wednesday, January 24th. The stock was sold at an average price of $70.00, for a total value of $210,000.00. Following the completion of the sale, the chief financial officer now owns 84,775 shares in the company, valued at approximately $5,934,250. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Michael Pray sold 5,944 shares of the stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $70.47, for a total value of $418,873.68. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 24,010 shares of company stock worth $1,630,556. 5.80% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: This article was reported by Week Herald and is owned by of Week Herald. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://weekherald.com/2018/02/15/medidata-solutions-inc-to-post-q1-2018-earnings-of-0-17-per-share-dougherty-co-forecasts-mdso.html.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.